-
1
-
-
84879145293
-
Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh
-
Alam S, Noor EASM, Chowdhury ZR, Alam M, Kabir J. Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh. World J Hepatol. 2013;5:281-287. doi: 10.4254/wjh.v5.i5. 28JLPMID: 23717739
-
(2013)
World J Hepatol.
, vol.5
, pp. 281-287
-
-
Alam, S.1
Noor, E.A.S.M.2
Chowdhury, Z.R.3
Alam, M.4
Kabir, J.5
-
2
-
-
84892838265
-
Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
-
24574727
-
Du J, Ma YY, Yu CH, Li YM. Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol. 2014;20:569-577. doi: 10.3748/wjq.v20.i2.569 PMID: 24574727
-
(2014)
World J Gastroenterol.
, vol.20
, pp. 569-577
-
-
Du, J.1
Ma, Y.Y.2
Yu, C.H.3
Li, Y.M.4
-
3
-
-
34250323865
-
Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis
-
17518368
-
Hirose A, Ono M, Saibara T, Nozaki Y, Masuda K, Yoshioka A, et al. Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology. 2007;45:1375-1381. PMID: 17518368
-
(2007)
Hepatology
, vol.45
, pp. 1375-1381
-
-
Hirose, A.1
Ono, M.2
Saibara, T.3
Nozaki, Y.4
Masuda, K.5
Yoshioka, A.6
-
4
-
-
58849134985
-
Long-term follow-up of patients with nonalcoholic fatty liver
-
19049831
-
Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7:234-238. doi: 10.1016/i.cqh.2008.11. 005 PMID: 19049831
-
(2009)
Clin Gastroenterol Hepatol.
, vol.7
, pp. 234-238
-
-
Rafiq, N.1
Bai, C.2
Fang, Y.3
Srishord, M.4
McCullough, A.5
Gramlich, T.6
-
5
-
-
84894257853
-
Clinical approaches to non-alcoholic fatty liver disease
-
24587650
-
Schwenger KJ, Allard JP. Clinical approaches to non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20:1712-1723. doi: 10.3748/wjq.v20.i7.1712 PMID: 24587650
-
(2014)
World J Gastroenterol.
, vol.20
, pp. 1712-1723
-
-
Schwenger, K.J.1
Allard, J.P.2
-
6
-
-
84880335250
-
The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis
-
23875831
-
Semba T, Nishimura M, Nishimura S, Ohara O, Ishige T, Ohno S, et al. The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis. BMC Gastroenterol. 2013;13:120. doi: 10.1186/1471-230X-13-120 PMID: 23875831
-
(2013)
BMC Gastroenterol.
, vol.13
, pp. 120
-
-
Semba, T.1
Nishimura, M.2
Nishimura, S.3
Ohara, O.4
Ishige, T.5
Ohno, S.6
-
7
-
-
84884176199
-
Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance
-
23833274
-
Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol. 2013;218:R25-36. doi: 10.1530/JOE-13-0201 PMID: 23833274
-
(2013)
J Endocrinol.
, vol.218
, pp. R25-R36
-
-
Asrih, M.1
Jornayvaz, F.R.2
-
8
-
-
84898670730
-
Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: Prospective cohort- and cross-sectional phenotyping studies
-
24643166
-
Stefan N, Sun Q, Fritsche A, Machann J, Schick F, Gerst F, et al. Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies. PLoS One. 2014;9:e92238. doi: 10.1371/joumal.pone.0Q92238 PMID: 24643166
-
(2014)
PLoS One
, vol.9
, pp. e92238
-
-
Stefan, N.1
Sun, Q.2
Fritsche, A.3
Machann, J.4
Schick, F.5
Gerst, F.6
-
9
-
-
41849123475
-
Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: Implications for treatment
-
18177455
-
Carter-Kent C, Zein NN, Feldstein AE. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am J Gastroenterol. 2008;103:1036-1042. doi: 10. 1111/j.1572-0241.2007.01709.x PMID: 18177455
-
(2008)
Am J Gastroenterol.
, vol.103
, pp. 1036-1042
-
-
Carter-Kent, C.1
Zein, N.N.2
Feldstein, A.E.3
-
10
-
-
38349107613
-
Adipokines and cytokines in non-alcoholic fatty liver disease
-
18081738
-
Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008;27:412-421. PMID: 18081738
-
(2008)
Aliment Pharmacol Ther.
, vol.27
, pp. 412-421
-
-
Jarrar, M.H.1
Baranova, A.2
Collantes, R.3
Ranard, B.4
Stepanova, M.5
-
11
-
-
74549198657
-
Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH)
-
19996485
-
Krawczyk K, Szczesniak P, Kumor A, Jasinska A, Omulecka A, Pietruczuk M, et al. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH). J Physiol Pharmacol. 2009;60 Suppl 3:71-75. PMID: 19996485
-
(2009)
J Physiol Pharmacol.
, vol.60
, pp. 71-75
-
-
Krawczyk, K.1
Szczesniak, P.2
Kumor, A.3
Jasinska, A.4
Omulecka, A.5
Pietruczuk, M.6
-
12
-
-
33745386896
-
Tumor necrosis factor-alpha and interleukin-1 beta increases CTRP1 expression in adipose tissue
-
16806199
-
Kim KY, Kim HY, Kim JH, Lee CH, Kim DH, Lee YH, et al. Tumor necrosis factor-alpha and interleukin-1 beta increases CTRP1 expression in adipose tissue. FEBS Lett. 2006;580:3953-3960. PMID: 16806199
-
(2006)
FEBS Lett.
, vol.580
, pp. 3953-3960
-
-
Kim, K.Y.1
Kim, H.Y.2
Kim, J.H.3
Lee, C.H.4
Kim, D.H.5
Lee, Y.H.6
-
13
-
-
84855511415
-
CTRP1 protein enhances fatty acid oxidation via AMP-activated protein kinase (AMPK) activation and acetyl-CoA carboxylase (ACC) inhibition
-
22086915
-
Peterson JM, Aja S, Wei Z, Wong GW. CTRP1 protein enhances fatty acid oxidation via AMP-activated protein kinase (AMPK) activation and acetyl-CoA carboxylase (ACC) inhibition. J Biol Chem. 2012;287:1576-1587. doi: 10.1074/jbc. M111.278333 PMID: 22086915
-
(2012)
J Biol Chem.
, vol.287
, pp. 1576-1587
-
-
Peterson, J.M.1
Aja, S.2
Wei, Z.3
Wong, G.W.4
-
14
-
-
84901459654
-
Metabolic function of the CTRP family of hormones
-
23963681
-
Seldin MM, Tan SY, Wong GW. Metabolic function of the CTRP family of hormones. Rev EndocrMetab Disord. 2014;15:111-123. doi: 10.1007/s11154-013-9255-7 PMID: 23963681
-
(2014)
Rev EndocrMetab Disord.
, vol.15
, pp. 111-123
-
-
Seldin, M.M.1
Tan, S.Y.2
Wong, G.W.3
-
15
-
-
84871756657
-
Development of a novel enzyme-linked immunosorbent assay (ELISA) for measurement of serum CTRP1: A pilot study: Measurement of serum CTRP1 in healthy donors and patients with metabolic syndrome
-
23000311
-
Chalupova L, Zakovska A, Adamcova K. Development of a novel enzyme-linked immunosorbent assay (ELISA) for measurement of serum CTRP1: a pilot study: measurement of serum CTRP1 in healthy donors and patients with metabolic syndrome. Clin Biochem. 2013;46:73-78. doi: 10.1016/j. clinbiochem.2012.09.006 PMID: 23000311
-
(2013)
Clin Biochem.
, vol.46
, pp. 73-78
-
-
Chalupova, L.1
Zakovska, A.2
Adamcova, K.3
-
16
-
-
30444437494
-
ClqTNF-related protein-1 (CTRP-1): A vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen
-
16195328
-
Lasser G, Guchhait P, Ellsworth JL, Sheppard P, Lewis K, Bishop P, et al. ClqTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen. Blood. 2006;107:423-430. PMID: 16195328
-
(2006)
Blood
, vol.107
, pp. 423-430
-
-
Lasser, G.1
Guchhait, P.2
Ellsworth, J.L.3
Sheppard, P.4
Lewis, K.5
Bishop, P.6
-
17
-
-
84858749562
-
CTRP family: Linking immunity to metabolism
-
22261190
-
Schaffler A, Buechler C. CTRP family: linking immunity to metabolism. Trends Endocrinol Metab. 2012;23:194-204. doi: 10.1016/j.tem.2011.12.003 PMID: 22261190
-
(2012)
Trends Endocrinol Metab.
, vol.23
, pp. 194-204
-
-
Schaffler, A.1
Buechler, C.2
-
18
-
-
58149315989
-
I. Molecular, biochemical and functional characterizations of Clq/TNF family members: Adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions
-
18783346
-
Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Revett T, Gimeno R, Lodish HF. I. Molecular, biochemical and functional characterizations of Clq/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J. 2008;416:161-177. doi: 10.1042/BJ20081240 PMID: 18783346
-
(2008)
Biochem J.
, vol.416
, pp. 161-177
-
-
Wong, G.W.1
Krawczyk, S.A.2
Kitidis-Mitrokostas, C.3
Revett, T.4
Gimeno, R.5
Lodish, H.F.6
-
19
-
-
58149314003
-
Adiponectin: No longer the lone soul in the fight against insulin resistance?
-
18990088
-
Davis KE, Scherer PE. Adiponectin: no longer the lone soul in the fight against insulin resistance? Biochem J. 2008;416:e7-9. doi: 10.1042/BJ20082033 PMID: 18990088
-
(2008)
Biochem J
, vol.416
, pp. e7-e9
-
-
Davis, K.E.1
Scherer, P.E.2
-
20
-
-
84901370223
-
Circulating complement-C1q TNF-related protein 1 levels are increased in patients with type 2 diabetes and are associated with insulin sensitivity in Chinese subjects
-
24827430
-
Pan X, Lu T, Wu F, Jin L, Zhang Y, Shi L, et al. Circulating complement-C1q TNF-related protein 1 levels are increased in patients with type 2 diabetes and are associated with insulin sensitivity in Chinese subjects. PLoS One. 2014;9:e94478. doi: 10.1371/joumal.pone.0Q94478 PMID: 24827430
-
(2014)
PLoS One.
, vol.9
, pp. e94478
-
-
Pan, X.1
Lu, T.2
Wu, F.3
Jin, L.4
Zhang, Y.5
Shi, L.6
-
21
-
-
84903384872
-
Association of circulating ClqATNF-related protein 1 levels with coronary artery disease in men
-
24945145
-
Yuasa D, Ohashi K, Shibata R, Takeshita K, Kikuchi R, Takahashi R, et al. Association of Circulating ClqATNF-Related Protein 1 Levels with Coronary Artery Disease in Men. PLoS One. 2014;9:e99846. doi: 10.1371/joumal.pone.0099846 PMID: 24945145
-
(2014)
PLoS One
, vol.9
, pp. e99846
-
-
Yuasa, D.1
Ohashi, K.2
Shibata, R.3
Takeshita, K.4
Kikuchi, R.5
Takahashi, R.6
-
22
-
-
9644265298
-
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease
-
15582127
-
Angulo P, Alba LM, Petrovic LM, Adams LA, Lindor KD, Jensen MD. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol. 2004;41:943-949. PMID: 15582127
-
(2004)
J Hepatol.
, vol.41
, pp. 943-949
-
-
Angulo, P.1
Alba, L.M.2
Petrovic, L.M.3
Adams, L.A.4
Lindor, K.D.5
Jensen, M.D.6
-
23
-
-
79959517565
-
Human fatty liver disease: Old questions and new insights
-
21700865
-
Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science. 2011;332:1519-1523. doi: 10.1126/science.1204265 PMID: 21700865
-
(2011)
Science
, vol.332
, pp. 1519-1523
-
-
Cohen, J.C.1
Horton, J.D.2
Hobbs, H.H.3
-
24
-
-
84863098121
-
Inflammation andfibrogenesis in steatohepatitis
-
22310735
-
Fujii H, Kawada N. Inflammation andfibrogenesis in steatohepatitis. J Gastroenterol. 2012;47:215-225. doi: 10.1007/S00535-012-0527-x PMID: 22310735
-
(2012)
J Gastroenterol.
, vol.47
, pp. 215-225
-
-
Fujii, H.1
Kawada, N.2
-
25
-
-
70549105648
-
Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease
-
19559819 1229. e1221-1222
-
Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Rafiq N, et al. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:1224-1229, 1229. e1221-1222. doi: 10.1016/i.cqh.2009.06.007 PMID: 19559819
-
(2009)
Clin Gastroenterol Hepatol.
, vol.7
, pp. 1224-1229
-
-
Hossain, N.1
Afendy, A.2
Stepanova, M.3
Nader, F.4
Srishord, M.5
Rafiq, N.6
-
26
-
-
84876727580
-
Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD)
-
23092327
-
Podrini C, Borghesan M, Greco A, Pazienza V, Mazzoccoli G, Vinciguerra M. Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD). Curr Pharm Des. 2013;19:2737-2746. PMID: 23092327
-
(2013)
Curr Pharm Des.
, vol.19
, pp. 2737-2746
-
-
Podrini, C.1
Borghesan, M.2
Greco, A.3
Pazienza, V.4
Mazzoccoli, G.5
Vinciguerra, M.6
-
27
-
-
0347364706
-
Doesleptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?
-
14687831
-
Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, et al. Doesleptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am J Gastroenterol. 2003;98:2771-2776. PMID: 14687831
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2771-2776
-
-
Chalasani, N.1
Crabb, D.W.2
Cummings, O.W.3
Kwo, P.Y.4
Asghar, A.5
Pandya, P.K.6
-
28
-
-
0037135523
-
Disruption of adiponectin causes insulin resistance and neointimal formation
-
12032136
-
Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002;277:25863-25866. PMID: 12032136
-
(2002)
J Biol Chem.
, vol.277
, pp. 25863-25866
-
-
Kubota, N.1
Terauchi, Y.2
Yamauchi, T.3
Kubota, T.4
Moroi, M.5
Matsui, J.6
-
29
-
-
0037144394
-
Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin
-
12151381
-
Ma K, Cabrero A, Saha PK, Kojima H, Li L, Chang BH, et al. Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem. 2002;277:34658-34661. PMID: 12151381
-
(2002)
J Biol Chem.
, vol.277
, pp. 34658-34661
-
-
Ma, K.1
Cabrero, A.2
Saha, P.K.3
Kojima, H.4
Li, L.5
Chang, B.H.6
-
30
-
-
84875679556
-
Nonalcoholic fatty liver disease: An emerging threat to obese and diabetic individuals
-
23363012
-
Masuoka HC, Chalasani N. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann N Y Acad Sci. 2013;1281:106-122. doi: 10.1111/nvas. 12016 PMID: 23363012
-
(2013)
Ann N Y Acad Sci.
, vol.1281
, pp. 106-122
-
-
Masuoka, H.C.1
Chalasani, N.2
-
31
-
-
0036177589
-
Hyperinsulinemiain nondiabetic, both obese and nonobese patients with nonalcoholic steatohepatitis
-
11866303
-
Sonsuz A, Basaranoglu M, Bilir M, Senturk H, Akin P. Hyperinsulinemiain nondiabetic, both obese and nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2002;97:495. PMID: 11866303
-
(2002)
Am J Gastroenterol.
, vol.97
, pp. 495
-
-
Sonsuz, A.1
Basaranoglu, M.2
Bilir, M.3
Senturk, H.4
Akin, P.5
-
32
-
-
33748111665
-
Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance
-
16952562
-
Tilg H, Hotamisligil GS. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology. 2006;131:934-945. PMID: 16952562
-
(2006)
Gastroenterology
, vol.131
, pp. 934-945
-
-
Tilg, H.1
Hotamisligil, G.S.2
-
33
-
-
84907517814
-
Elevated circulating levels of CTRP1, a novel adipokine, in diabetic patients
-
24965225
-
Xin Y, Lyu X, Wang C, Fu Y, Zhang S, Tian C, et al. Elevated circulating levels of CTRP1, a novel adipokine, in diabetic patients. Endocr J. 2014;61(9):841-847. PMID: 24965225
-
(2014)
Endocr J.
, vol.61
, Issue.9
, pp. 841-847
-
-
Xin, Y.1
Lyu, X.2
Wang, C.3
Fu, Y.4
Zhang, S.5
Tian, C.6
-
34
-
-
0036063777
-
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
-
12068289
-
Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8:731-737. PMID: 12068289
-
(2002)
Nat Med.
, vol.8
, pp. 731-737
-
-
Maeda, N.1
Shimomura, I.2
Kishida, K.3
Nishizawa, H.4
Matsuda, M.5
Nagaretani, H.6
-
35
-
-
13244295710
-
Plasma adiponectin is decreased in nonalcoholic fatty liver disease
-
15762194
-
Pagano C, Soardo G, Esposito W, Fallo F, Basan L, Donnini D, et al. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol. 2005;152(1):113-118. PMID: 15762194
-
(2005)
Eur J Endocrinol.
, vol.152
, Issue.1
, pp. 113-118
-
-
Pagano, C.1
Soardo, G.2
Esposito, W.3
Fallo, F.4
Basan, L.5
Donnini, D.6
-
36
-
-
84908386184
-
Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients
-
25267016
-
Wree A, Schlattjan M, Bechmann LP, Claudel T, Sowa JP, Stojakovic T, et al. Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients. Metabolism. 2014;63(12):1542-1552. doi: 10.1016/i.metabol.2014.09.001 PMID: 25267016
-
(2014)
Metabolism.
, vol.63
, Issue.12
, pp. 1542-1552
-
-
Wree, A.1
Schlattjan, M.2
Bechmann, L.P.3
Claudel, T.4
Sowa, J.P.5
Stojakovic, T.6
|